Tablets, 185mg Now Available by Prescription in the United StatesBEDMINSTER, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- ...
Alembic Pharma receives USFDA approval for generic Lamotrigine tablets, used to treat seizures. ANDA equivalent to GlaxoSmithKline's Lamictal.
Lamotrigine is primarily used to treat seizures. According to IQVIA data, the estimated market size for the product is $27 ...
Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Lamotrigine ...
Alembic Pharmaceuticals completed a USFDA cGMP inspection at its Karakhadi Injectable Facility (F-3) from February 9–18, 2026. The inspection ended with two observations, none related to data ...
Alembic Pharma receives US FDA approval for lamotrigine orally disintegrating tablets USP, 25 mg, 50 mg, 100 mg & 200 mg: Our Bureau, Mumbai Thursday, February 26, 2026, 14:15 Hrs ...
Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Lamotrigine Orally Disintegrating ...
Alembic Pharmaceuticals, an India-based API maker, is selling its formulation manufacturing plant in Baddi to Scott Edil Pharmacia for an undisclosed amount, according to a filing (PDF) with the ...
Alembic Pharmaceuticals has received final approval from the USFDA for its Lamotrigine orally disintegrating tablets used in the treatment of various seizure disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results